Overactive Bladder Syndrome Clinical Trial
Official title:
Randomized,Single-Blind Controlled Trial
This experiment is expected to understand the benefits of different settings of electrical stimulation in the treatment of overactive bladder.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | February 28, 2019 |
Est. primary completion date | November 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Urinary incontinence due to detrusor overactivity - No patients had been taking anticholinergics or tricyclic depressants and none had been treated by pelvic floor exercise, bladder training, or pelvic surgery before entry into the study. Exclusion Criteria: - stress incontinence - urinary tract infection - neurological disease - genital prolapse higher than stage II on POP-Q system - pregnancy - diabetes mellitus - a history of anti-incontinence surgery and/or prolapse repair - pelvic tumors and previously treated with radiation therapy or antimuscarinic agents - patients who were not cooperative - electrical stimulation contraindications |
Country | Name | City | State |
---|---|---|---|
Taiwan | Chung Shan Medical University Hospital | Taichung |
Lead Sponsor | Collaborator |
---|---|
Chung Shan Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 3 Days Voiding diary | This chart is a record of your voiding and leakage or urine. Choose three (3) separate 24 hour periods to complete this record. Pick days which will be most convenient for you to measure every void. | 3 days | |
Secondary | Overactive Bladder Symptom Score( OABSS) | This is a single symptom score that employs a self-report questionnaire to quantify OAB symptoms.Questionnaire has many items with the same minimum and maximum score.Four question items, daytime frequency, nocturia, urgency and urgency incontinence, were included in the questionnaire according to the definition of OAB. | 20 min | |
Secondary | minVisual analogue scale (VAS) for urgency | The Visual Analog or Analogue Scale (VAS) is designed to present to the respondent a rating scale with minimum constraints. Respondents mark the location on the 10-centimeter line corresponding to the amount of urgency they experienced. This gives them the greatest freedom to choose their urgency intensity. It also gives the maximum opportunity for each respondent to express a personal response style. VAS data of this type is recorded as the number of millimeters from the left of the line with the range 0-100. | 10 min | |
Secondary | Pad test | To measure leakage and may be performed in the specialist's office or at home. Pad testing can be done over a period of time as short as twenty minutes or up to one hour. | 20min-1hr |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02540707 -
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
|
Phase 4 | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT06438861 -
Role of Combination Therapy in Women With Refractory Overactive Bladder
|
N/A | |
Completed |
NCT01114412 -
Basic Sensations Coming From the Bladder
|
||
Recruiting |
NCT06045728 -
Telerehabilitation for Overactive Bladder Syndrome in Obese Women
|
N/A | |
Recruiting |
NCT03952299 -
Oxybutynin for Post-surgical Bladder Pain and Urgency
|
Phase 3 | |
Active, not recruiting |
NCT03758235 -
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
|
Phase 3 | |
Completed |
NCT01912885 -
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
|
N/A | |
Completed |
NCT04300400 -
Treatment of the Overactive Bladder Syndrome: A Delphi Study
|
||
Recruiting |
NCT04982120 -
Use of Repris Needle in Bladder Injection
|
N/A | |
Completed |
NCT06123364 -
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
|
N/A | |
Recruiting |
NCT06088394 -
Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder
|
N/A | |
Recruiting |
NCT05221021 -
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
|
Phase 4 | |
Terminated |
NCT04256876 -
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
|
N/A | |
Not yet recruiting |
NCT03331081 -
Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome
|
N/A | |
Recruiting |
NCT04873037 -
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
|
N/A | |
Completed |
NCT02024945 -
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
|
Phase 4 | |
Completed |
NCT00546637 -
Fesoterodine "add-on" Male Overactive Bladder Study
|
Phase 3 | |
Not yet recruiting |
NCT06143397 -
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
|
N/A | |
Recruiting |
NCT03044912 -
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
|
Phase 3 |